KLSC Urges Caution on Proposed COINS Act Restrictions to Protect Access to Innovative Medicines 

KLSC supports the Administration’s efforts to protect national security and strengthen America's global competitiveness. However, the proposed expansion of the COINS Act to include restrictions on U.S. investment in China's biotechnology sector risks unintended consequences for medical progress and patient access to new therapies.